{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:13Z","timestamp":1788539053025,"version":"build-2803163510"},"reference-count":38,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Building Stronger Universities phase III","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,10,12]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>There is a concern about performance of the screening approaches, where information on the quality of novel and affordable screening approaches that will perform well in remote areas is warranted. This lack of information makes it difficult to prioritise resource use in efforts to improve cervical cancer outcomes. We aimed to compare the diagnostic value of human papillomavirus (HPV) testing on self-collected samples, Pap smear and visual inspection of the cervix with acetic acid (VIA) tests for detection of high-grade cervical intraepithelial neoplasia or worse (CIN2+).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A combined cross-sectional and cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Three primary healthcare centres in Kilimanjaro region, Tanzania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1620\u2009women undergoing cervical cancer screening from December 2018 to September 2021. Inclusion criteria were being aged 25\u201360 years, and no history of premalignant or cervical cancer. Exclusion criteria were overt signs of cancer and previous hysterectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants underwent HPV self-sampling with Evalyn Brush and Care HPV kit assay was used to determine prevalence of high-risk HPV infection. Women with positive HPV test were together with a random sample of HPV negative women scheduled for follow-up where VIA was performed, and Pap smear and cervical biopsies obtained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1620 women enrolled, 229 (14.1%) were HPV positive and 222 of these attended follow-up together with 290 (20.8%) women with negative HPV test. On VIA, 17.6% were positive. On Pap smear, 8.0% were classified as high-grade squamous intraepithelial lesion. The sensitivity and specificity, respectively, of the various tests, compared with histopathology for the detection of CIN2+ were: HPV test 62.5%, 59.3%; Pap smear 82.8%, 82.1% and; VIA 48.4%, 56.8%. When combined, the sensitivity and specificity for HPV and Pap smear were 90.6%, 70.6% while HPV and VIA were 65.6% and 75.5% for the detection of CIN2+.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The performance of care HPV testing on self-collected samples opens the possibility of increasing coverage and early detection in resource-constrained settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-064321","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T12:36:02Z","timestamp":1667219762000},"page":"e064321","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Performance of HPV testing, Pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern Tanzania: a cross-sectional study nested in a cohort"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-0168","authenticated-orcid":false,"given":"Alex","family":"Mremi","sequence":"first","affiliation":[{"name":"Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, United Republic of Tanzania"},{"name":"Department of Obstetrics and Gynecology, Kilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bariki","family":"Mchome","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania"},{"name":"Department of Obstetrics and Gynecology, Kilimanjaro Christian Medical Centre, Moshi, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mlay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania"},{"name":"Department of Obstetrics and Gynecology, Kilimanjaro Christian Medical Centre, Moshi, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Schledermann","sequence":"additional","affiliation":[{"name":"Department of Pathology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Blaak\u00e6r","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Southern Denmark, Odense, Denmark"},{"name":"Department of Obstetrics and Gynecology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Rasch","sequence":"additional","affiliation":[{"name":"Odense University Hospital, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"},{"name":"Department of Clinical Research, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2025121422190691000_12.10.e064321.1","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025121422190691000_12.10.e064321.2","unstructured":"International Agency for Cancer Research . Tanzania, United Republic of. source: Globocan, 2018: international agency for cancer research; 2018. available from. Available: https:\/\/gco.iarc.fr\/today\/data\/ factsheets\/populations\/834-tanzania-united-republic-of-fact-sheets.pdf"},{"key":"2025121422190691000_12.10.e064321.3","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054012"},{"key":"2025121422190691000_12.10.e064321.4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28712"},{"key":"2025121422190691000_12.10.e064321.5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.aogh.2014.09.014","article-title":"Screening for cancer in low- and middle-income countries","volume":"80","author":"Sankaranarayanan","year":"2014","journal-title":"Ann Glob Health"},{"key":"2025121422190691000_12.10.e064321.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218559","article-title":"Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: a cross-sectional study","volume":"14","author":"Katanga","year":"2019","journal-title":"PLoS One"},{"key":"2025121422190691000_12.10.e064321.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-020-00917-7","article-title":"\u201cThe best thing is that you are doing it for yourself\u201d \u2013 perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study","volume":"20","author":"Bakiewicz","year":"2020","journal-title":"BMC Womens Health"},{"key":"2025121422190691000_12.10.e064321.8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/aogs.14117","article-title":"Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: a cross-sectional study nested in a cohort in rural Tanzania","volume":"100","author":"Mremi","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025121422190691000_12.10.e064321.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2018.00077","article-title":"Self-Sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs","volume":"6","author":"Gupta","year":"2018","journal-title":"Front Public Health"},{"key":"2025121422190691000_12.10.e064321.10","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-021-00380-5","article-title":"Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Tesfahunei","year":"2021","journal-title":"Infect Agent Cancer"},{"key":"2025121422190691000_12.10.e064321.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70570-9"},{"key":"2025121422190691000_12.10.e064321.12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000201676","article-title":"Cervical cancer control in the era of HPV vaccination and novel biomarkers","volume":"76","author":"Wentzensen","year":"2009","journal-title":"Pathobiology"},{"key":"2025121422190691000_12.10.e064321.13","unstructured":"World Health Organization . Global strategy towards eliminating cervical cancer as a public health problem, 2020. Available: https:\/\/www.who.int\/docs\/default-source\/cervical-cancer\/cerv-cancer-elimn-strategy-16dec-12pm.pdf"},{"key":"2025121422190691000_12.10.e064321.14","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle-income countries","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol Lett"},{"key":"2025121422190691000_12.10.e064321.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3084"},{"key":"2025121422190691000_12.10.e064321.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003528","article-title":"Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: a cohort study","volume":"18","author":"Kelly","year":"2021","journal-title":"PLoS Med"},{"key":"2025121422190691000_12.10.e064321.17","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1003"},{"key":"2025121422190691000_12.10.e064321.18","unstructured":"United Nations population estimates and projections . World population prospects 2019 revision. Available: https:\/\/worldpopulationreview.com\/countries\/tanzania-population [Accessed 18 Aug 2022]."},{"key":"2025121422190691000_12.10.e064321.19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/bjc.2016.207","article-title":"Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study","volume":"115","author":"Segondy","year":"2016","journal-title":"Br J Cancer"},{"key":"2025121422190691000_12.10.e064321.20","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000084"},{"key":"2025121422190691000_12.10.e064321.21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0000000000000115","article-title":"The Pap Test and Bethesda 2014: \"The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)\"","volume":"19","author":"Nayar","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"2025121422190691000_12.10.e064321.22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ijgo.13090","article-title":"HPV-Based cervical cancer screening in low-resource settings: maximizing the efficiency of community-based strategies in rural Kenya","volume":"148","author":"Huchko","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121422190691000_12.10.e064321.23","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/01.aids.0000432472.92120.1b","article-title":"Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy","volume":"27","author":"Chung","year":"2013","journal-title":"AIDS"},{"key":"2025121422190691000_12.10.e064321.24","unstructured":"World Health Organization (WHO) . Guidelines for screening and treatment of cervical pre-cancerous lesions for cervical cancer prevention: WHO guidelines. Geneva WHO; 2021."},{"key":"2025121422190691000_12.10.e064321.25","unstructured":"National Cancer Institute . Cervical Cancer Treatment (PDQR)\u2013Health Professional Version. Available: ttps:\/\/www.cancer.gov\/types\/cervical\/hp\/cervical-treatment-pdq#link\/_576"},{"key":"2025121422190691000_12.10.e064321.26","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000084"},{"key":"2025121422190691000_12.10.e064321.27","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00175"},{"key":"2025121422190691000_12.10.e064321.28","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.33029","article-title":"A demonstration of automated visual evaluation of cervical images taken with a smartphone camera","volume":"147","author":"Xue","year":"2020","journal-title":"Int J Cancer"},{"key":"2025121422190691000_12.10.e064321.29","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-020-00324-5","article-title":"Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage","volume":"15","author":"Desai","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"2025121422190691000_12.10.e064321.30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jnci\/djy225","article-title":"An observational study of deep learning and automated evaluation of cervical images for cancer screening","volume":"111","author":"Hu","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2025121422190691000_12.10.e064321.31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tjog.2019.03.010","article-title":"Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening","volume":"58","author":"Vahedpoor","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2025121422190691000_12.10.e064321.32","first-page":"192","article-title":"Visual inspection of cervix with acetic acid: a good alternative to pap smear for cervical cancer screening in resource-limited setting","volume":"65","author":"Khan","year":"2015","journal-title":"J Pak Med Assoc"},{"key":"2025121422190691000_12.10.e064321.33","doi-asserted-by":"publisher","DOI":"10.1258\/td.2009.090085"},{"key":"2025121422190691000_12.10.e064321.34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/10105395211006600","article-title":"Cervical cancer screening among immigrant women residing in Australia: a systematic review","volume":"33","author":"Alam","year":"2021","journal-title":"Asia Pac J Public Health"},{"key":"2025121422190691000_12.10.e064321.35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5858\/135.2.191","article-title":"Pathology practice in a resource-poor setting: Mwanza, Tanzania","volume":"135","author":"Rambau","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"2025121422190691000_12.10.e064321.36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5858\/arpa.2011-0587-ED","article-title":"The practice of pathology in Africa","volume":"137","author":"Kaschula","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"2025121422190691000_12.10.e064321.37","unstructured":"UICC . Cervical cancer elimination in Africa: where are we now and where do we need be? 2022 [Accessed 22 Aug 2022]."},{"key":"2025121422190691000_12.10.e064321.38","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5575"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-064321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:19:18Z","timestamp":1765779558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-064321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,31]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjopen-2022-064321"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-064321","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}